| Date Filed | Type | Description |
| 03/13/2021 |
GN
| STOCK ALERT: Halper Sadeh LLP Investigates MGLN, CATM, EGOV, ALXN; Shareholders Are Encouraged to Contact the Firm |
| 01/01/2021 |
GN
| MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages RP, MDCA, ALXN, SPWH Shareholders to Contact the Firm |
| 12/15/2020 |
GN
| ALEXION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ALXN and Encourages Investors to Contact the Firm |
| 12/15/2020 |
GN
| SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – ALXN, PS, HBAN, CKH |
| 12/14/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout |
| 12/19/2019 |
GN
| Achillion Shareholders Approve Agreement to be Acquired by Alexion |
| 10/29/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations |
| 03/06/2019 |
GN
| Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions — Research Highlights Growth, Revenue, and Consolidated Results |
| 08/08/2018 |
GN
| Recent Analysis Shows Washington Real Estate Investment Trust, FirstEnergy, Alexion Pharmaceuticals, Alaska Air Group, Fortune Brands Home & Security, and Baxter International Market Influences — Renewed Outlook, Key Drivers of Growth |
| 04/26/2018 |
BW
| Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study |
| 04/12/2018 |
BW
| Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018 |
| 02/08/2018 |
BW
| Alexion Reports Fourth Quarter and Full Year 2017 Results and Provides Financial Guidance for 2018 |
| 01/31/2018 |
BW
| Alexion to Present at the Leerink Partners 7th Annual Global Healthcare Conference |
| 01/18/2018 |
BW
| Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018 |
| 01/02/2018 |
BW
| Alexion to Present at the 36th Annual J.P. Morgan Healthcare Conference |
| 12/20/2017 |
BW
| Alexion to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference |
| 12/06/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Intuit, Alexion Pharmaceuticals, Salesforce, Jack In The Box, MedEquities Realty Trust, and Fiesta Restaurant Group — New Research Emphasizes Economic Growth |
| 11/27/2017 |
BW
| Alexion to Present at the Citi 2017 Global Healthcare Conference |
| 10/26/2017 |
BW
| Alexion Reports Third Quarter 2017 Results |
| 10/10/2017 |
BW
| Alexion to Report Third Quarter 2017 Results on Thursday, October 26, 2017 |
| 09/12/2017 |
BW
| Alexion Announces Restructuring to Advance Corporate Strategy |
| 09/05/2017 |
BW
| Alexion to Present at Upcoming Investor Conferences |
| 07/27/2017 |
BW
| Alexion Reports Second Quarter 2017 Results |
| 07/11/2017 |
BW
| Alexion to Report Second Quarter 2017 Results and Strategic Update on Thursday, July 27, 2017 |
| 05/30/2017 |
BW
| Alexion to Present at Upcoming Investor Conferences |
| 05/09/2017 |
BW
| Alexion to Present at the Bank of America Merrill Lynch 2017 Health Care Conference |
| 04/27/2017 |
BW
| Alexion Reports First Quarter 2017 Results |
| 04/06/2017 |
BW
| Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017 |
| 03/16/2017 |
GN
| Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate |
| 02/16/2017 |
BW
| Alexion Reports Fourth Quarter and Full Year 2016 Results and Provides Financial Guidance for 2017 |
| 07/21/2011 |
BW
| Alexion Reports Second Quarter 2011 Results |
| 06/20/2011 |
BW
| Alexion Initiates Clinical Trial of Eculizumab as a Potential Treatment for Patients with STEC-HUS in Expanded Response to EHEC Crisis in Germany |
| 06/07/2011 |
BW
| Alexion to Present at the 31st Annual William Blair & Company Growth Stock Conference |
| 05/31/2011 |
BW
| Alexion to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference |
|